Article
Cost-effectiveness of interferon alfa-2b with and without ribavirin as therapy for chronic hepatitis C in Sweden.
Scandinavian journal of gastroenterology - 1 Aug 2001
Sennfält K, Reichard O, Hultkrantz R, Wong J B, Jonsson D
Abstract excerpt
BACKGROUND: Recent trials have shown that treatment with a combination of interferon alfa-2b and ribavirin results in sustained loss of detectable hepatitis C-virus (HCV) RNA in a higher proportion of patients than treatment with interferon alone. Combination therapy, however, is two to three times as expensive as monotherapy. METHODS: Based on data from recent randomized clinical trials and a previously...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.